Verzeichnis wissenschaftlicher Veröffentlichungen

Professor Bernhard Lembcke

1) Originalarbeiten (Zeitschriften mit peer review)

< Zurück zu PublikationenVorwärts zu Übersichten >

1.96. D. Faust, F. Menge, F.P. Armbruster, B. Lembcke, J. Stein. Increased Serum Bone Sialoprotein Concentrations in Patients with Crohn´s Disease. Z. Gastroenterol. 2003; 41: 243-47

1.95. T. Wehrmann, J. Grotkamp, N. Stergiou, A. Riphaus, A. Kluge, B. Lembcke, A. Schultz.Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: A randomized, controlled trial. Gastrointest. Endosc. 2002; 56: 817 - 824

1.94. B. Braden, M. Enghofer, M. Schaub, K.H. Usadel, W.F. Caspary, B. Lembcke. Long-term cisapride treatment improves diabetic gastroparesis but without influence on glycaemic control. Aliment. Pharmacol. Ther. 2002; 16: 1341-1346

1.93. C.F. Dietrich, M. Chichakli, T.O. Hirche, J. Bargon, P. Leitzmann, T.O.F. Wagner, B. Lembcke. Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosis. Ultrasound Med. 2002; 21: 409 - 416

1.92. T. Wehrmann, N. Stergiou, A. Riphaus, B. Lembcke. Correlation between sphincter of Oddi manometry and intraductal ultrasound morphology in patients with suspected sphincter of Oddi dysfunction. Endoscopy 2001; 33: 773 - 777

1.91. T. Wehrmann, T.H. Schmitt, A. Arndt, B. Lembcke, W.F. Caspary, H. Seifert. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of oddi dysfunction. Aliment. Pharmacol. Ther. 2000; 14: 1469-1477

1.90. C.F. Dietrich, B. Lembcke, H. Seifert, W.F. Caspary, T. Wehrmann. Sonographische Diagnostik der Penizillin-induzierten segmentär-hämorrhagischen Colitis. Dtsch. Med. Wschr. 2000; 125: 755-760

1.89. M. Freye, J. Bargon, B. Lembcke, T.O.F. Wagner, R. Gropp. Differential expression of human - and ß-defensins mRNA in gastrointestinal epithelia. Eur. J. Clin. Invest. 2000; 30: 695-701

1.88. B. Braden, G. Teuber, C.F. Dietrich, W.F. Caspary, B. Lembcke. Comparison of new faecal antigen test with 13C-urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: prospective clinical evaluation. BMJ 2000; 320: 148

1.87. C.F. Dietrich, V. Brunner, H. Seifert, D. Schreiber-Dietrich, W.F. Caspary, B. Lembcke. Sonographischer Beitrag zur Diagnostik und Verlaufsbeurteilung der einheimischen Sprue. Ultraschall Med. 1999; 20: 242-247

1.86. T. Wehrmann, B. Lembcke, W.F. Caspary, H. Seifert. Sphincter of Oddi dysfunction after successful gallstone lithotripsy (postlithotripsy syndrome): manometric data and results of endoscopic sphincterotomy. Dig. Dis. Sci. 1999; 44: 2244-50

1.85. C.F. Dietrich, T. Wehrmann, S. Zeuzem, B. Braden, W.F. Caspary, B. Lembcke. Analysis of hepatic echo patterns in chronic hepatitis C. Ultraschall Med. 1999; 20: 9-14

1.84. B. Braden, W.F. Caspary, B. Lembcke. Nondispersive infrared spectrometry for 13CO2/12CO2-measurements: A clinically feasible analyzer for stable isotope breath tests in gastroenterology. Z. Gastroenterol. 1999; 37: 477-481

1.83. T. Wehrmann, S. Kokabpick, B. Lembcke, W.F. Caspary, H. Seifert. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest. Endosc. 1999; 49: 677-83

1.82. T. Wehrmann, S. Kokabpick, V. Jacobi, H. Seifert, B. Lembcke, W.F. Caspary. Endoscopic injection of botulinum toxin in elderly achalasia-patients with tortuous megaesophagus or epiphrenic diverticulum. Endoscopy 1999; 31: 352-358

1.81. T. Wehrmann, H. Seifert, M. Seipp, B. Lembcke, W.F. Caspary. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 1998; 30: 702-707

1.80. B. Lembcke, J. Specht, G. Nippel, W. Caspary. Struktur- und Ergebnisqualität deutschsprachiger Gastroskopie-Aufklärungsbögen aus Patientensicht. Z. Gastroenterol. 1998; 36: 829-838

1.79. B. Braden, A. Wenke, H-J. Karich, C.F. Dietrich, I. Scharrer, W.F. Caspary, B. Lembcke. Risk of gastrointestinal bleeding associated with Helicobacter pylori infection in patientswith hemophilia or von Willebrand´s syndrome. Helicobacter 1998; 3: 184-187.

1.78. B. Braden, W.F. Caspary, B. Lembcke. The density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms. Dig. Dis. Sci. 1997;
42: 2120-2123.

1.77. T. Wehrmann, H. Aharonoff, C.F. Dietrich, W.F. Caspary, B. Lembcke. Erlauben sonographische Parameter die Diagnose einer biliären Sphincter Oddi-Dysfunktion ? Z. Gastroenterol. 1997; 35: 449-457.

1.76. T. Wehrmann, S. Marek, E. Hanisch, B. Lembcke, W.F. Caspary. Causes and management of recurrent biliary pain after successful nonoperative gallstone treatment. Am. J. Gastroenterol. 1997; 92: 132-138.

1.75. C.F. Dietrich, H. Schall, J. Kirchner, H. Seifert, G. Herrmann, W.F. Caspary, B. Lembcke: Sonographic detection of focal changes in the liver hilus in patients receiving corticosteroid therapy. Z. Gastroenterol. 1997; 35: 1051-1057.

1.74. M. Pohl, B. Krackhardt, H.G. Posselt, B. Lembcke. Ultrasound studies of the intestinal wall in patients with cystic fibrosis. J. Ped. Gastroenterol. Nutr. 1997; 25: 317-320.

1.73. B. Braden, L.P. Duan, W.F. Caspary, B. Lembcke. Endoscopy is not a risk factor for Helicobacter pylori infection - but medical practice is. Gastrointest. Endoscopy 1997; 46: 305-310.

1.72. B. Braden, H. Picard, W.F. Caspary, B. Lembcke. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: Evidence for normalized fat assimilation with high dose pancreatin therapy. Z. Gastroenterol. 1997; 35: 123-129.

1.71. T. Wehrmann, K. Wiemer, B. Lembcke. Ösophagus- und anorektale Motilität bei Patienten mit Sphinkter-Oddi-Dysfunktion. Z. Gastroenterol. 1996; 34: 483-489.

1.70. B. Lembcke, B. Braden, W.F. Caspary. Exocrine pancreatic insufficiency: accuracy and clinical value of the uniformly labeled 13C-Hiolein breath test. Gut 1996; 39 : 668-674.

1.69. P.G. Lankisch, A. Marinez Schramm, F. Petersen, M. Dröge, D. Lehnick, B. Lembcke. Diagnostic latency in coeliac disease. Z. Gastroenterol. 1996; 34: 473-477.

1.68. W. Pommerien, V. Schultze, B. Braden, B. Lembcke, M. Wrangstadh, W. Londong. Dose-Response of Omeprazole Combined with Amoxicillin on Duodenal Ulcer Healing and Eradication of Helicobacter Pylori. Aliment. Pharmacol. Ther. 1996 ; 10: 303-308.

1.67. P.G. Lankisch, M. Dröge, S. Hofses, H. König, D. Lehnick, B. Lembcke. Steatorrhoea: You cannot trust your eyes when it comes to diagnosis. Lancet 1996; 347: 1620-1621.

1.66. B. Braden, F. Schäfer, W.F. Caspary, B. Lembcke. Nondispersive isotope-selective infrared spectroscopy: a new analytical method for 13C-urea breath tests. Scand. J. Gastroenterol. 1996; 31: 442-445.

1.65. J. Stein, D. Schoonbroodt, M. Jung, B. Lembcke, W.F. Caspary. Mesure de l´élastase 1 fécale par immunoréactivé: une nouvelle approche indirecte de la fonction pancréatique. Gastroenterol. Clin. Biol. 1996; 20: 424-429.

1.64. J. Stein, B. Purschian, S. Zeuzem, B. Lembcke , W.F. Caspary. Quantification of fecal carbohydrates by near-infrared reflectance analysis. Clin. Chem. 1996; 42: 309-312.

1.63. J. Stein, M. Jung, A. Sziegoleit, S. Zeuzem, W.F. Caspary, B. Lembcke. Immunoreactive elastase 1: clinical evaluation of a new noninvasive test of pancreatic function. Clin. Chem. 1996; 42: 222-226.

1.62. T. Wehrmann, K. Wiemer, B. Lembcke, W.F. Caspary, M. Jung. Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy ? A 5-year prospective trial. Europ. J. Hepatol. Gastroenterol. 1996; 8: 251-256.

1.61. T. Wehrmann, K. Wiemer, B. Lembcke, M. Jung. Effect of endoscopic sphincterotomy on sphincter of Oddi manometry results in patients with or without papillary stenosis: Z. Gastroenterol. 1995; 33: 662-668.

1.60. L.P. Duan, B. Braden, W.F. Caspary, B. Lembcke. The influence of Cisapride on gastric emptying of solids and liquids monitored by 13C-breath tests. Dig. Dis. Sci. 1995; 40: 2200-2206.

1.59. B. Braden, S. Adam, L.P. Duan, K.-H. Orth, F. Maul, B. Lembcke, G. Hör, W.F. Caspary. 13C-acetate breath test accurately reflects gastric emptying of liquids both in liquid and semisolid test meals. Gastroenterology 1995; 108: 1048-1055.

1.58. M. Ott, H. Fischer, H. Polat, E.B. Helm, M. Frenz, W.F. Caspary, B. Lembcke. Bioelectrical impedance analysis as a predictor of survival in patients with the human immunodeficiency virus-infection. J AIDS 1995; 9: 20-25.

1.57. T. Wehrmann, N. Kleemann, W.F. Caspary, B. Lembcke. Does pretreatment with bile acids enhance efficacy of biliary extracorporeal shock wave lithotripsy ? Z. Gastroenterol. 1995; 33: 155-158.

1.56. T. Wehrmann, V. Jacobi, M. Jung, B. Lembcke, W.F. Caspary. Pneumatic dilation in achalasia with a low-compliance balloon. Results of a 5-year prospective evaluation. Gastrointest. Endoscopy 1995; 42: 31-36.

1.55. B. Lembcke, O. Konle, L.P. Duan, W.F. Caspary. Lack of accuracy of plasma- amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas by secretin and cholecystokinin-pancreozymin. Z. Gastroenterol. 1994; 32: 679-683.

1.54. T. Wehrmann, D. Fremdling, B. Lembcke, M. Jung. Endoscopic injection of epinephrinealone is equally effective as epinephrine and polidocanol for treatment of bleeding pepticulcers. A prospective, randomized evaluation with endoscopic monitoring of bleeding activity. Europ. J. Gastroenterol. Hepatol. 1994; 6: 1033-1038.

1.53. B. Lembcke, B. Wickenkamp, A. Engelfried, W.F. Caspary. Evaluation des "Schulungsprogramms Zöliakie/Sprue" - Einfluß des Programms auf Beratungsbedarf, Wissen, Verhalten und Einstellung. Akt. Ernähr.-Med. 1994; 19: 302-306.

1.52. B. Braden, M. Haisch, L.P. Duan, B. Lembcke, W.F. Caspary, P. Hering. Clinically feasible stable isotope technique at a reasonable price: analysis of 13CO2/12CO2-abundance in breath samples with a new isotope selective nondispersive infrared spectrometer. Z. Gastroenterol. 1994; 32: 675-678.

1.51. A. Falkenbach, B. Lembcke, M. Schneider, R. Wiegand, R. Mulert-Ernst, W. Caspary. Polyserositis with adult Still's disease onset during pregnancy. Clin. Rheumatol. 1994; 13: 513-517.

1.50. J. Stein, B. Purschian, U. Bieniek, W.F. Caspary, B. Lembcke. Near infrared reflectance analysis (NIRA): A new dimension in the investigation of malabsorption syndromes. Europ. J. Gastroenterol. Hepatol. 1994; 6: 889-894.

1.49. L.P. Duan, B. Braden, Th. Clement, W.F. Caspary, B. Lembcke. Clinical evaluation of a miniaturized desktop breath hydrogen analyzer. Z. Gastroenterol. 1994; 32: 575-578.

1.48. J. Stein, E.H. Scheuermann, R. Yazdi, B. Lembcke, W.F. Caspary. Reduced postheparin plasma diamine oxidase activity in patients with chronic renal failure. Z. Gastroenterol. 1994; 32: 236-239.

1.47. B. Braden, L.P. Duan, W.F. Caspary, B. Lembcke. More convenient 13C-urea breath test modifications still meet the criteria for valid diagnosis of Helicobacter pylori infection. Z. Gastroenterol. 1994; 32: 198-202.

1.46. M. Ott, A. Wegner, W.F. Caspary, B. Lembcke. Intestinal absorption and malnutrition in patients with the acquired immunodeficiency syndrome (AIDS). Z. Gastroenterol. 1993; 31: 661-665.

1.45. T. Wehrmann, U. Rudolph, B. Lembcke, W.F. Caspary. Roxithromycin and erythromycin exert different effects on postprandial antroduodenal motor function and gastrointestinal symptoms in healthy subjects. Europ. J. Gastroenterol. Hepatol. 1993; 5: 829-834.

1.44. B. Braden, C.P. Braden, M. Klutz, B. Lembcke. Wasserstoff-(H2)-Atemgasanalytik in der gastroenterologischen Funktionsdiagnostik: Validierung eines Pocket-H2-Meßgerätes. Z. Gastroenterol. 1993; 31: 242-245.

1.43. M. Ott, B. Lembcke, H. Fischer, R. Jäger, H. Polat, H. Geier, M. Rech, S. Staszewski, E.B. Helm, W.F. Caspary. Early changes of body composition in HIV-infected patients. Neither body weight nor the body mass index but tetrapolar impedance analysis (BIA) indicates significant malnutrition. Am. J. Clin. Nutr. 1993; 57: 15-19.

1.42. T. Wehrmann, A. Hurst, B. Lembcke, M. Jung, W.F. Caspary. Biliary lithotripsy with a new electromagnetic shock wave source. - A 2 years clinical experience. Dig. Dis. Sci. 1993; 38: 1993; 2113-2120.

1.41. J. Stein, V. Milovic, B. Lembcke, W.F. Caspary. Characteristics of putrescine uptake by human brush border membrane vesicles. Z. Gastroenterol. 1992; 30: 841-845.

1.40. T. Wehrmann, P.H. Althoff, B. Lembcke, W.F. Caspary. Anale Inkontinenz bei Patienten mit Morbus Addison: eine gluco- und mineralocorticoid-unabhängige Sphincterstörung? Z. Gastroenterol. 1992; 30: 171-175.

1.39. J. Stein, A. Hahn, B. Lembcke, G. Rehner. High-performance liquid chromatographic determination of biotin in biological materials after crown ether-catalyzed fluorescence derivatization with panacylbromide. Anal. Biochem. 1992; 200: 89-94.

1.38. J. Stein, J. Kulemeier, B. Lembcke, W.F. Caspary. Simple and rapid method for determination of short-chain fatty acids in biological materials by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 1992; 576: 53-61.

1.37. B. Lembcke, R. Lamberts, J. Wöhler, W. Creutzfeldt. Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAY o 1248). A drug-induced pattern of hepatic glycogen storage mimicking POMPE's disease (glycogenosis type II). Res. Exp. Med. (Berl.) 1991; 191: 389-404.

1.36. T. Wehrmann, B. Lembcke, W.F. Caspary. Influence of cisapride on antroduodenal motor function in healthy subjects and diabetics with autonomic gastroparesis. Aliment. Pharmacol. Therapeut. 1991; 5: 599-608.

1.35. S. Güldütuna, A. Hellstern, M. Leuschner, W. Kurtz, B. Lembcke, K. Heller, U. Leuschner. Endoskopie, Stoßwellenlithotripsie und lokale Lyse bei komplizierten Pigmentsteinen der extra- und intrahepatischen Gallengänge. Dtsch. med. Wschr. 1991; 116: 288-293.

1.34. B. Lembcke, U.R. Fölsch, W. Gatzemeier, R. Ebert, E. Siegel, W. Creutzfeldt. Inhibition of glycemic and hormonal responses after repetitive sucrose and starch loads by different doses of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in man. Pharmacology 1991; 43: 318-328.

1.33. H. Rau, H. Fischer, K. Schmidt, B. Lembcke, P.-H. Althoff. Effect of bromocriptine withdrawal in acromegaly on body composition as assessed by bioelectrical impedance analysis. Acta Endocrinologica 1991; 125: 273-279.

1.32. U. Meckler, W.F. Caspary, T. Clement, P. Herzog, B. Lembcke, B. Limberg, A. El Mouaaouy, G. Nippel, P. Reuss, W.B. Schwerck, H. Worlicek. Sonographie beim Morbus Crohn - Stellungnahme einer Expertengruppe. Z. Gastroenterol. 1991; 29: 355-359.

1.31. M. Ott, B. Lembcke, S. Staszewski, E.B. Helm, W.F. Caspary. Intestinale Permeabilität bei Patienten mit erworbenem Immundefekt-Syndrom (AIDS). Klin. Wschr. 1991; 69: 715-721.

1.30. B. Lembcke, U.R. Fölsch, W. Gatzemeier, B. Lücke, R. Ebert, E. Siegel, W. Creutzfeldt. Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers. Europ. J. Clin. Pharmacol. 1991; 41: 561 - 567.

1.29. B. Lembcke, M. Diederich, U.R. Fölsch, W. Creutzfeldt. Postprandial glycaemic control, hormonal effects and carbohydrate malabsorption during long term administration of the alpha-glucosidase inhibitor miglitol. Digestion 1990; 47: 47-55.

1.28. B. Lembcke, Chr. Bornholdt, S. Kirchhoff, P.G. Lankisch. Clinical evaluation of a 25g D-xylose hydrogen (H2) breath test. Z. Gastroenterol. 1990; 28: 555-560.

1.27. S. Zeuzem, B. Lembcke, K. Hübner, V. Schwab, W.F. Caspary. Zystische Polyposis des Magens. Dtsch. med. Wschr. 1990; 115: 653-656.

1.26. M. Kindel, Helga Ludwig-Koehn, B. Lembcke. A new and versatile method for determination of faecal bile acids by thin-layer chromatography with direct scanning fluorimetry. J. Chromatogr. 1989; 497: 139-146.

1.25. B. Lembcke, H. Schneider, P.G. Lankisch. Is the assay of disaccharidase activity in small bowel mucosal biopsy relevant for clinical gastroenterologists ? Klin. Wschr. 1989; 67: 568-575.

1.24. B. Lembcke, K. Geibel, S. Kirchhoff, P.G. Lankisch. Serum-ß-Carotin: ein einfacher statischer Laborparameter für die Diagnostik der Steatorrhoe. Dtsch. med. Wschr. 1989; 114: 243-247.

1.23. P.G. Lankisch, J. Otto, J. Brauneis, R.Hilgers, B. Lembcke. Detection of pancreatic steatorrhea by oral pancreatic function tests. Dig. Dis. Sci. 1988; 33: 1233-1236.

1.22. P.G. Lankisch, B. Lembcke, S. Kirchhoff, R. Hilgers, W. Creutzfeldt. Therapie der pankreatogenen Steatorrhoe. Vergleich zweier säuregeschützter Enzympräparate. Dtsch. med. Wschr. 1988; 113: 15-17.

1.21. B. Lembcke, Chr. Löser, U.R. Fölsch, J. Wöhler, W. Creutzfeldt. Adaptive responses to pharmacological inhibition of small intestinal alpha-glucosidases in the rat. Gut 1987; 28 S1: 181-187.

1.20. B. Lembcke, K. Grimm, P.G. Lankisch. Raised fecal fat concentration does not differentiate pancreatic from other steatorrheas. Am. J. Gastroenterol. 1987; 82: 526-531.

B. Lembcke, P.G. Lankisch. Letter to the editor / Reply. Am. J. Gastroenterol. 1988; 83: 101-102.

1.19. B. Lembcke, W. Creutzfeldt, S. Schleser, R. Ebert, C. Shaw, I. Koop. Effect of the somatostatin analogue Sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987; 36: 108-124.

1.18. P.G. Lankisch, B. Lembcke, B. Göke, W. Creutzfeldt. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage ? Z. Gastroenterol. 1986; 24: 753-757.

1.17. B. Lembcke, A. Lösler, W.F. Caspary, P. Schürnbrand, D. Emrich, W. Creutzfeldt. Clinical value of a dual isotope fat absorption test system (FATS) using glycerol 125J-trioleate and glycerol 75Se-triether. Dig. Dis. Sci. 1986; 31: 822-828.

1.16. P.G. Lankisch, B. Lembcke, G. Wemken, W. Creutzfeldt. Functional reserve capacity of the exocrine pancreas. Digestion 1986; 35: 175-181.

1.15. B. Lembcke, H. Schneider, P.G. Lankisch. How safe is small bowel biopsy? Endoscopy 1986; 18: 80-83.

1.14. P.G. Lankisch, J. Otto, I. Erkelenz, B. Lembcke. Pancreatic calcifications: no indicator of severe exocrine pancreatic insufficiency. Gastroenterology 1986; 90: 617-621.

1.13. B. Elsenhans, R. Blume, B. Lembcke, W.F. Caspary. In vitro inhibition of rat small intestinal absorption by lipophilic organic cations. Biochim. Biophys. Acta 1985; 813: 25-32.

1.12. B. Lembcke, B. Kraus, P.G. Lankisch. Small intestinal function in chronic relapsing pancreatitis. Hepato-Gastroenterology 1985; 32: 149-151.

1.11. B. Lembcke, A. Kehl, P.G. Lankisch. Does an antifoaming agent improve the quality of abdominal ultrasonography ? Z. Gastroenterol. 1985; 23: 628-631.

1.10. B. Lembcke, U.R. Fölsch, W. Creutzfeldt. Effect of 1-desoxynojirimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro. Digestion 1985; 31: 120 - 127.

1.9. B. Lembcke, C. Fuchs. Magnesium Load Induced by Ingestion of Magnesium-Containing Antacids. Contr. Nephrol. 1984; 38: 185-194.

1.8. B. Lembcke, R. Ebert, M. Ptok, W.F. Caspary, W. Creutzfeldt, H. Schicha, D. Emrich. Role of gastrointestinal transit in the delay of absorption by viscous fibre (guar). Hepato-Gastroenterology 1984; 31: 183-186.

1.7. B. Lembcke, S. Kirchhoff, W.F. Caspary. Vereinfachte Methoden zur endexspiratorischen Wasserstoff (H2)-Analyse - klinische Erprobung zweier H2-Atemtestgeräte. Z. Gastroenterol. 1983; 21: 545-549.

1.6. B. Elsenhans, R. Blume, B. Lembcke, W.F. Caspary. Polycations. A new class of inhibitors for in vitro small intestinal transport of sugars and amino acids in the rat. Biochim. Biophys. Acta 1983; 727: 135-143.

1.5. B. Lembcke, C. Lembcke, W.F. Caspary. Transmural-gastrische Potentialdifferenz (PD) und intragastrales pH-Tagesprofil unter Proglumid. Z. Gastroenterol. 1983; 21: 342-350.

1.4. B. Lembcke, W.F. Caspary. Wasserstoff (H2)-Exhalationstests in der gastroenterologischen Funktionsdiagnostik - Apparative und methodische Aspekte. Lab. med. 1982; 6: 261-264.

1.3. B. Lembcke, U.R. Fölsch, W.F. Caspary, R. Ebert, W. Creutzfeldt. Influence of Metronidazole on the Breath Hydrogen Response and Symptoms in Acarbose-Induced Malabsorption of Sucrose. Digestion 1982; 25: 186-193.

1.2. B. Lembcke, K. Häsler, P. Kramer, W.F. Caspary, W. Creutzfeldt. Plasma digoxin concentrations during administration of dietary fibre (guar gum) in man. Z. Gastroenterol. 1982; 20: 164-167.

1.1. B. Lembcke, M. Hönig, W.F. Caspary. Different Actions of Neomycin and Metronidazole on Breath Hydrogen (H2) Exhalation. Z. Gastroenterol. 1980; 18: 155-160.

< Zurück zu PublikationenVorwärts zu Übersichten >